diosgenin has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, K; Fan, Q; Li, H; Liu, G; Liu, X; Ouyang, Z; Qin, A; Qu, X; Tang, T; Wu, C; Zhai, Z | 1 |
| Benghuzzi, H; Cason, Z; Higdon, K; Hughes, J; Puckett, A; Scott, A; Tsao, A; Tucci, M | 1 |
2 other study(ies) available for diosgenin and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Dioscin inhibits osteoclast differentiation and bone resorption though down-regulating the Akt signaling cascades.
Topics: Animals; Bone Resorption; Cell Differentiation; Diosgenin; Down-Regulation; Mice; Osteoblasts; Osteoclasts; Osteogenesis; Proto-Oncogene Proteins c-akt; Signal Transduction; Treatment Outcome | 2014 |
The prevention of osteoporotic progression by means of steroid loaded TCPL drug delivery systems.
Topics: Animals; Bone Resorption; Calcium Phosphates; Dehydroepiandrosterone; Diosgenin; Disease Progression; Drug Delivery Systems; Drug Implants; Estradiol; Female; Lysine; Osteoporosis; Ovariectomy; Phosphates; Rats; Rats, Sprague-Dawley | 2001 |